Source: startupticker

HemaXis: DBS System launches HemaXis DB with FDA listing in the US

DBS System has launched their HemaXis DB micro blood collection device in the United States with an FDA Class 1 medical device listing. HemaXis DB is DBS System's first generation device for the collection, transport and storage of capillary whole blood samples.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Eric Odman's photo - Co-Founder & CEO of HemaXis

Co-Founder & CEO

Eric Odman

CEO Approval Rating

85/100

Read more